![]() |
市場調査レポート
商品コード
1452931
外傷固定器具の世界市場、2024-2031年Global Trauma Fixation Devices Market 2024-2031 |
||||||
カスタマイズ可能
|
外傷固定器具の世界市場、2024-2031年 |
出版日: 2024年02月02日
発行: Orion Market Research
ページ情報: 英文 198 Pages
納期: 2~3営業日
|
世界の外傷固定器具市場は、予測期間(2024-2031年)にCAGR 7.4%で成長すると予測されます。外傷固定器具市場の重要な寄与要因としては、変性骨疾患の増加、外傷固定器具の研究開発投資の増加、外傷や事故事例の増加などが挙げられます。英国政府が提供した国家統計によると、2022年には29,742人が死亡または重傷(KSI)の死傷者となり、1,711件の死亡事故が登録され、135,480人がすべての重症度の死傷者となりました。その結果、英国では外科手術の件数が増加しています。
材料の中では、生体吸収性材料サブセグメントが世界の外傷固定器具市場でかなりのシェアを占めると予想されています。このセグメントの成長は、除去手術の必要性の減少、生体材料技術の継続的な進歩、規制当局の承認に起因しています。2023年3月、Bioretec Ltd.は骨折治癒のための生体吸収性マグネシウム合金インプラントであるRemeOs(TM)trauma screwのFDA市場認可を取得しました。RemeOs(TM)は、従来のチタン製やスチール製のインプラントに取って代わり、除去手術の必要性をなくし、手術成績を向上させることを目的としています。RemeOs(TM)は整形外科クリニックの経営目標をサポートし、足首骨折患者の価値提案を改善します。
外傷固定器具の世界市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、中南米)を含む地域別にさらに細分化されています。このうち、欧州は世界全体で突出したシェアを占めると予想されています。スポーツ関連傷害の急増を含む重要な要因の1つが、外傷固定ソリューションの需要を押し上げました。2023年米国国立衛生研究所(NIH)の調査「2021/22年ラグビー欧州傷害サーベイランス報告書」によると:SuperCup, Under-20, and Under-18 Championship "と題されたNIHの調査によると、学校および18歳以下の選手の負傷率は、1000人試合時間あたり47人以下と報告されており、これはシニア成人男子の国際大会における負傷率の約半分です。
すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の市場成長は、整形外科手術の罹患率の上昇、労働災害を含む不慮の傷害の罹患率の上昇につながる工業化の進展、骨折や整形外科外傷などの外傷の有病率の上昇に起因しています。米国労働統計局によると、2022年に米国で記録された死亡労働災害は5,486件で、2021年の5,190件から5.7%増加しました。死亡労働災害率はフルタイム換算労働者10万人当たり3.7人で、2021年のフルタイム換算労働者10万人当たり3.6人から上昇しました。このような要因から、主要な主要企業は市場の需要に対応するために製品を導入することが奨励されています。2023年9月、Orthofix Medical社は米国でGalaxy Fixation Geminiシステムを発売しました。下肢および上肢の外傷による骨折を治療するための安定した体外固定システムです。
Global Trauma Fixation Devices Market Size, Share & Trends Analysis Report by Product Type (Internal Fixators and External Fixators), by Material (Stainless Steel, Titanium, and Bioabsorbable Materials), by Applications (Upper Extremities, Lower Extremities, Spine, and Others), and by End-User (Hospitals, Ambulatory Surgical Centers (ASCs), and Trauma Centers) Forecast Period (2024-2031)
The global trauma fixation devices market is anticipated to grow at a CAGR of 7.4% during the forecast period (2024-2031). Significant factors contributing to the trauma fixation devices market include the rising of degenerative bone disorders, increasing investment in R&D of the trauma fixation devices, and increasing number of trauma and accident cases. According to the national statistics provided by the UK government, in 2022, 29,742 people were killed or seriously injured (KSI) casualties, 1,711 fatality cases were registered and 135,480 were casualties of all severities. As a result, the number of surgical procedures is increasing in the UK.
The global trauma fixation devices market is segmented by product type, material, application, and end-user. Based on the product types, the market is sub-segmented into internal fixators and external fixators. Internal fixators include plates and screws, rods and pins, wires and cables, intramedullary nails, and cannulated screws. External fixators include unilateral and bilateral fixators, circular fixators, and hybrid fixators. Based on the materials, the market is sub-segmented into stainless steel, titanium, and bioabsorbable materials. Based on the applications, the market is sub-segmented into upper extremities, lower extremities, spine, and others (rib fixation). Further, based on the end-user, the market is sub-segmented into hospitals, ambulatory surgical centers, and trauma centers. Among the materials, the bioabsorbable material sub-segment is projected to hold a significant share of the market, owing to the rising adoption of bioabsorbable materials in trauma devices degrade in the body, eliminating the need for removal surgeries and improving outcomes in orthopedic treatment.
Among the materials, the bioabsorbable materials sub-segment is expected to hold a considerable share of the global trauma fixation devices market. The segmental growth is attributed to the reduced need for removal surgery, and continuous advancements in biomaterials technology, regulatory approvals. In March 2023, Bioretec Ltd. received FDA market authorization for its RemeOs(TM) trauma screw, a bioresorbable magnesium alloy implant for bone fracture healing. It aimed to replace traditional titanium and steel implants, eliminating the need for removal surgery, and enhancing surgical outcomes. RemeOs(TM) supports operational goals for orthopedic clinics and improves the value proposition for patients with ankle fractures.
The global trauma fixation devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe. One of the significant factors, including a surge in sports-related injuries, boosted the demand for trauma fixation solutions. According to the 2023 National Institutes of Health (NIH) study titled "2021/22 Rugby Europe Injury Surveillance Report: SuperCup, Under-20, and Under-18 Championship," school and under-18 athletes reported injury rates below 47 per 1000 player-match-hours, about half of those in senior adult male international competitions.
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. The regional market growth is attributed to the rising incidence of orthopedic surgeries, the increasing industrialization leading to a heightened incidence of unintentional injuries including workplace injuries, and the increasing prevalence of traumatic injuries such as fractures and orthopedic trauma. According to the US Bureau of Labor Statistics, there were 5,486 fatal work injuries recorded in the US in 2022, marking a 5.7% increase from the 5,190 recorded in 2021. The fatal work injury rate was 3.7 fatalities per 100,000 full-time equivalent workers, up from 3.6 per 100,000 full-time equivalents in 2021. Owing to such factors, major key players are encouraged to introduce the product to address the prevailing market demand. In September 2023, Orthofix Medical launched its Galaxy Fixation Gemini system in the US. A stable external fixation system for treating trauma-induced fractures in the lower and upper limbs.
The major companies serving the global trauma fixation devices market include CONMED Corp., DePuy Synthes (a Johnson & Johnson company), Integra LifeSciences Holdings Corp., Smith & Nephew Plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2024, Extremity Medical LLC partnered with Henry Schein, Inc., a global healthcare solutions company, expanding its orthopedic extremity implant systems. The collaboration aimed to enhance healthcare outcomes globally.